Neumora Therapeutics (NMRA) Non Operating Income (2022 - 2026)
Neumora Therapeutics' Non Operating Income was -$892,000 in Q2 2026, compared with $1.33 million a year earlier.
Powered by 
Analysis
Neumora Therapeutics (NMRA) Non Operating Income (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Neumora Therapeutics' Non Operating Income was -$1.48 million through Jun 30, 2026; for FY2025, it was $4.36 million, down 78.1% from FY2024.
- Non Operating Income shows a three-year compound annual growth rate of -4.3% (FY2022 to FY2025).
- In earlier years, Non Operating Income was $19.86 million in FY2024 (+20.8%), $16.44 million in FY2023 (+231.1%) and $4.97 million in FY2022.
- Quarterly Non Operating Income has moved between -$970,000 (Q4 2025) and $6.35 million (Q1 2024) over five years.
- Compared with a year earlier, Non Operating Income was higher in 1 of the last five quarters, with an average decline of 44.3%.
- The best year-over-year quarter for Non Operating Income over five years was Q3 2023 (growth of 205.0%); the worst was Q3 2025 (a decline of 77.2%).
- Per Business Quant data, NMRA's Non Operating Income in the three quarters before Q2 2026 was -$564,000 (Q1 2026), -$970,000 (Q4 2025) and $945,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Neumora Therapeutics | 129.65 Mn | 129.65 Mn | - | -892,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -892,000.00 |
| Mar 31, 2026 | -564,000.00 |
| Dec 31, 2025 | -970,000.00 |
| Sep 30, 2025 | 945,000.00 |
| Jun 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Dec 31, 2024 | 4.10 Mn |
| Sep 30, 2024 | 4.15 Mn |
| Jun 30, 2024 | 5.25 Mn |
| Mar 31, 2024 | 6.35 Mn |
| Dec 31, 2023 | 5.54 Mn |
| Sep 30, 2023 | 3.84 Mn |
| Jun 30, 2023 | 3.52 Mn |
| Mar 31, 2023 | 3.54 Mn |
| Dec 31, 2022 | 2.57 Mn |
| Sep 30, 2022 | 1.26 Mn |
API Access
Neumora Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=NMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();